| Utestående aktier | 68,634,329 shares |
| Insideraktier | 15 621 902 shares |
| Insynsägande | 22,76 % |
| Totalt antal insynspersoner | 33 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
-0.063 %( )
10432 out of 11220Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Olema Pharmaceuticals, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Biotechnology Value Fund Ii Lp - | 471 350 | 347 970 | |
|
Biotechnology Value Fund L P
10% Owner -
|
471 350 | 347 970 | |
| Cynthia M Butitta Director - [D] | 83 876 | 83 876 | |
|
Bvf Gp Holdings Llc
10% Owner -
|
471 350 | 347 970 | |
|
Bvf I Gp Llc
10% Owner -
|
471 350 | 347 970 | |
| Bvf Ii Gp Llc - | 471 350 | 347 970 | |
|
Bvf Inc/il
10% Owner -
|
471 350 | 347 970 | |
| Bvf Partners L P/il Director - [D] | 347 970 | 347 970 | |
| BVF Partners OS Ltd. - | 471 350 | 347 970 | |
|
Bain Capital Life Sciences Investors, LLC
10% Owner -
|
4 300 000 | 4 300 000 | |
| Biotechnology Value Trading Fund OS LP - | 471 350 | 347 970 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Sean Bohen PRESIDENT AND CEO, Director - [D] [O] | 241 662 | 241 662 | |
| Ian T Clark | 21 520 | ||
|
Bihua Chen
Director, 10% Owner -
[D]
|
3 270 544 | 3 270 544 | |
| Cormorant Asset Management, LLC - | 3 270 544 | 3 270 544 | |
|
Cormorant Global Healthcare Master Fund, LP
10% Owner -
|
3 270 544 | 3 270 544 | |
|
Cormorant Private Healthcare Fund II, LP
10% Owner -
|
3 270 544 | 3 270 544 | |
|
Cormorant Private Healthcare Fund III LP
10% Owner -
|
3 270 544 | 3 270 544 | |
| Graham G. Walmsley Director - [D] | 1 408 875 | 1 408 875 | |
| Cyrus Harmon Director - [D] | 117 028 | 117 028 | |
| Kinney Horn CHIEF BUSINESS OFFICER - [O] | 2 458 | 2 458 | |
| Sandra Horning | 86 083 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Gorjan Hrustanovic | 21 520 | ||
| Shane William Charles Kovacs CH. OPERATING & FINANCIAL OFF. - [O] | 543 549 | 543 549 | |
| Kushner Peter J. Chief Scientific Officer - [O] | 1 431 672 | 1 431 672 | |
|
Mark N Lampert
10% Owner -
|
471 350 | 347 970 | |
| Frank Mccormick Director - [D] | 84 260 | 84 260 | |
| John B Moriarty | 166 250 | ||
| Myles David C. CH. DISCOV. & NON-CLIN DEV OFF - [O] | 766 010 | 766 010 | |
|
Paradigm Biocapital Advisors LP
10% Owner -
|
783 118 | 783 118 | |
| Andrew Rappaport Director - [D] | 385 965 | 385 965 | |
|
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
10% Owner -
|
1 725 406 | 1 725 406 | |
| Naseem Zojwalla CHIEF MEDICAL OFFICER - [O] | 129 509 | 129 509 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i OLMA / Olema Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i OLMA / Olema Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-18 | 2025-09-18 | 4 | Harmon Cyrus | OLMA | Common Stock | I | 8,3200 | −3 086 | −26 | 117 028 | ||||
| 2025-09-18 | 2025-09-18 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 8,3300 | −10 000 | −83 | 744 140 | ||||
| 2025-09-18 | 2025-09-16 | 4 | Harmon Cyrus | OLMA | Common Stock | I | 8,0800 | −1 914 | −15 | 120 114 | ||||
| 2025-09-18 | 2025-09-16 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 8,0400 | −10 000 | −80 | 754 140 | ||||
| 2025-01-14 | 2025-01-10 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | −22 740 | 347 970 | ||||||
| 2025-01-14 | 2025-01-10 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | −161 810 | 2 003 966 | ||||||
| 2025-01-14 | 2025-01-10 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | −235 450 | 2 655 977 | ||||||
| 2025-01-13 | 2025-01-10 | 4 | Bain Capital Life Sciences Investors, LLC See footnotes | OLMA | Common Stock | I | −3 500 000 | 4 300 000 | ||||||
| 2025-01-13 | 2025-01-08 | 4 | Bain Capital Life Sciences Investors, LLC See footnotes | OLMA | Common Stock | I | 5,7579 | 300 000 | 1 727 | 7 800 000 | ||||
| 2025-01-13 | 3 | Bain Capital Life Sciences Investors, LLC See footnotes | OLMA | Common Stock | I | 7 500 000 | ||||||||
| 2024-12-18 | 2024-12-13 | 4/A | Graham G. Walmsley See note | OLMA | Common Stock | I | 6,7500 | 700 761 | 4 730 | 700 761 | ||||
| 2024-12-18 | 2024-12-13 | 4/A | Graham G. Walmsley See note | OLMA | Common Stock | I | 6,7500 | −700 761 | −4 730 | 0 | ||||
| 2024-12-17 | 2024-12-17 | 4 | Graham G. Walmsley See note | OLMA | Common Stock | I | 6,7500 | −700 761 | −4 730 | 1 408 875 | ||||
| 2024-12-17 | 2024-12-17 | 4 | Graham G. Walmsley See note | OLMA | Common Stock | I | 6,7500 | −700 761 | −4 730 | 0 | ||||
| 2024-12-17 | 2024-12-16 | 4 | Zojwalla Naseem | OLMA | Common Stock | D | 4,8700 | 14 000 | 68 | 129 509 | ||||
| 2024-12-11 | 2024-12-11 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 9,3900 | −179 | −2 | 764 140 | ||||
| 2024-12-11 | 2024-12-11 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 8,6600 | −7 958 | −69 | 764 319 | ||||
| 2024-12-11 | 2024-12-10 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 9,3700 | −8 256 | −77 | 772 277 | ||||
| 2024-12-11 | 2024-12-09 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 29 250 | 780 533 | ||||||
| 2024-12-11 | 2024-12-11 | 4 | Myles David C. | OLMA | Common Stock | D | 9,3900 | −300 | −3 | 598 333 | ||||
| 2024-12-11 | 2024-12-11 | 4 | Myles David C. | OLMA | Common Stock | D | 8,6600 | −13 314 | −115 | 598 633 | ||||
| 2024-12-11 | 2024-12-10 | 4 | Myles David C. | OLMA | Common Stock | D | 9,3800 | −12 452 | −117 | 611 947 | ||||
| 2024-12-11 | 2024-12-09 | 4 | Myles David C. | OLMA | Common Stock | D | 48 750 | 624 399 | ||||||
| 2024-12-11 | 2024-12-11 | 4 | Kovacs Shane William Charles | OLMA | Common Stock | D | 9,3900 | −406 | −4 | 543 549 | ||||
| 2024-12-11 | 2024-12-11 | 4 | Kovacs Shane William Charles | OLMA | Common Stock | D | 8,6600 | −17 950 | −155 | 543 955 | ||||
| 2024-12-11 | 2024-12-10 | 4 | Kovacs Shane William Charles | OLMA | Common Stock | D | 9,3700 | −16 803 | −157 | 561 905 | ||||
| 2024-12-11 | 2024-12-09 | 4 | Kovacs Shane William Charles | OLMA | Common Stock | D | 68 250 | 578 708 | ||||||
| 2024-12-11 | 2024-12-11 | 4 | Zojwalla Naseem | OLMA | Common Stock | D | 9,3900 | −320 | −3 | 115 509 | ||||
| 2024-12-11 | 2024-12-11 | 4 | Zojwalla Naseem | OLMA | Common Stock | D | 8,6600 | −14 202 | −123 | 115 829 | ||||
| 2024-12-11 | 2024-12-10 | 4 | Zojwalla Naseem | OLMA | Common Stock | D | 9,3700 | −13 283 | −124 | 130 031 | ||||
| 2024-12-11 | 2024-12-09 | 4 | Zojwalla Naseem | OLMA | Common Stock | D | 52 000 | 143 314 | ||||||
| 2024-12-11 | 2024-12-11 | 4 | Bohen Sean | OLMA | Common Stock | D | 9,3900 | −1 267 | −12 | 241 662 | ||||
| 2024-12-11 | 2024-12-11 | 4 | Bohen Sean | OLMA | Common Stock | D | 8,6600 | −55 907 | −484 | 242 929 | ||||
| 2024-12-11 | 2024-12-10 | 4 | Bohen Sean | OLMA | Common Stock | D | 9,3700 | −52 328 | −490 | 298 836 | ||||
| 2024-12-11 | 2024-12-09 | 4 | Bohen Sean | OLMA | Common Stock | D | 204 750 | 351 164 | ||||||
| 2024-12-04 | 2024-12-04 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | −153 441 | 370 710 | ||||||
| 2024-12-04 | 2024-12-04 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | −1 418 736 | 2 165 776 | ||||||
| 2024-12-04 | 2024-12-04 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | −1 797 527 | 2 891 427 | ||||||
| 2024-11-26 | 2024-06-04 | 4/A | Graham G. Walmsley See note | OLMA | Common Stock | I | 14,8500 | −475 000 | −7 054 | 708 114 | ||||
| 2024-11-26 | 2024-06-04 | 4/A | Graham G. Walmsley See note | OLMA | Common Stock | I | 14,8500 | −700 000 | −10 395 | 700 761 | ||||
| 2024-11-18 | 2024-11-15 | 4 | Kovacs Shane William Charles | OLMA | Common Stock | D | 7,0200 | 25 000 | 176 | 510 458 | ||||
| 2024-08-05 | 2024-08-01 | 4 | Paradigm Biocapital Advisors LP By: One or more separately managed accounts | OLMA | Common Stock, par value $0.0001 per share | I | 14,9150 | −529 501 | −7 898 | 783 118 | ||||
| 2024-08-05 | 2024-08-01 | 4 | Paradigm Biocapital Advisors LP By: Paradigm BioCapital International Fund Ltd. | OLMA | Common Stock, par value $0.0001 per share | I | 14,9150 | −1 870 499 | −27 898 | 4 720 482 | ||||
| 2024-07-31 | 2024-07-30 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 15,5500 | −934 | −15 | 751 283 | ||||
| 2024-07-31 | 2024-07-29 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 15,5800 | −4 066 | −63 | 752 217 | ||||
| 2024-07-12 | 2024-07-11 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 12,2600 | −5 000 | −61 | 756 283 | ||||
| 2024-07-02 | 2024-06-28 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 10,7700 | −20 000 | −215 | 761 283 | ||||
| 2024-06-06 | 2024-06-04 | 4 | Graham G. Walmsley See note | OLMA | Common Stock | I | 14,8500 | −475 000 | −7 054 | 708 114 | ||||
| 2024-06-06 | 2024-06-04 | 4 | Graham G. Walmsley See note | OLMA | Common Stock | I | 14,8500 | −700 000 | −10 395 | 700 761 | ||||
| 2024-06-04 | 2024-06-04 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 12,3300 | −5 000 | −62 | 781 283 | ||||
| 2024-06-04 | 2024-06-03 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 10,9300 | −5 000 | −55 | 786 283 | ||||
| 2024-06-04 | 2024-05-31 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 9,4100 | −15 000 | −141 | 791 283 | ||||
| 2024-05-28 | 2024-05-24 | 4 | Zojwalla Naseem | OLMA | Common Stock | D | 4,8700 | 9 460 | 46 | 89 824 | ||||
| 2024-05-07 | 2024-05-06 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 10,9200 | −5 000 | −55 | 806 283 | ||||
| 2024-05-02 | 2024-04-30 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 9,5100 | −15 000 | −143 | 811 283 | ||||
| 2024-03-29 | 2024-03-28 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 10,9700 | −20 000 | −219 | 826 283 | ||||
| 2024-03-20 | 2024-03-18 | 4 | Zojwalla Naseem | OLMA | Common Stock | D | 4,8700 | 13 700 | 67 | 80 364 | ||||
| 2024-03-06 | 2024-03-05 | 4 | RAPPAPORT ANDREW | OLMA | Common Stock | I | 385 965 | 385 965 | ||||||
| 2024-03-06 | 2024-03-05 | 4 | RAPPAPORT ANDREW | OLMA | Common Stock | I | −481 014 | 0 | ||||||
| 2024-03-04 | 2024-02-29 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 13,0000 | −100 | −1 | 846 283 | ||||
| 2024-03-04 | 2024-02-29 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 12,4100 | −24 900 | −309 | 846 383 | ||||
| 2024-02-02 | 2024-02-01 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 15,5600 | −5 000 | −78 | 871 283 | ||||
| 2024-02-02 | 2024-01-31 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 12,2300 | −25 000 | −306 | 876 283 | ||||
| 2024-01-29 | 2024-01-25 | 4 | Zojwalla Naseem | OLMA | Common Stock | D | 7,0200 | 20 000 | 140 | 66 664 | ||||
| 2024-01-16 | 2024-01-12 | 4 | Kovacs Shane William Charles | OLMA | Common Stock | D | 7,0200 | 50 000 | 351 | 484 987 | ||||
| 2024-01-02 | 2023-12-29 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 14,1000 | −2 500 | −35 | 901 283 | ||||
| 2024-01-02 | 2023-12-29 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 13,3000 | −22 500 | −299 | 903 783 | ||||
| 2023-12-18 | 2023-12-05 | 4 | Graham G. Walmsley See note | OLMA | Common Stock | I | 13,0850 | 50 000 | 654 | 1 800 000 | ||||
| 2023-12-18 | 2023-12-05 | 4 | Graham G. Walmsley See note | OLMA | Common Stock | I | 14,9496 | 50 000 | 747 | 1 750 000 | ||||
| 2023-12-18 | 2023-12-05 | 4 | Graham G. Walmsley See note | OLMA | Common Stock | I | 14,7333 | 31 870 | 470 | 1 700 000 | ||||
| 2023-12-18 | 2023-09-12 | 4 | Graham G. Walmsley See note | OLMA | Common Stock | I | 9,8400 | 508 130 | 5 000 | 1 668 130 | ||||
| 2023-12-12 | 2023-12-11 | 4 | Zojwalla Naseem | OLMA | Common Stock | D | 7,0200 | 2 900 | 20 | 46 664 | ||||
| 2023-12-12 | 2023-12-12 | 4 | Kovacs Shane William Charles | OLMA | Common Stock | D | 7,0200 | 10 000 | 70 | 434 987 | ||||
| 2023-12-08 | 2023-12-06 | 4 | Paradigm Biocapital Advisors LP By: Paradigm BioCapital International Fund Ltd. | OLMA | Common Stock, par value $0.0001 per share | I | 11,6000 | 100 000 | 1 160 | 6 590 981 | ||||
| 2023-12-07 | 2023-12-06 | 4 | Zojwalla Naseem | OLMA | Common Stock | D | 7,0200 | 13 100 | 92 | 43 764 | ||||
| 2023-12-01 | 2023-11-30 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 12,5700 | −25 000 | −314 | 926 283 | ||||
| 2023-11-22 | 2023-11-22 | 4 | Kovacs Shane William Charles | OLMA | Common Stock | D | 13,8900 | −9 145 | −127 | 424 987 | ||||
| 2023-11-22 | 2023-11-21 | 4 | Kovacs Shane William Charles | OLMA | Common Stock | D | 15,2700 | −700 | −11 | 434 132 | ||||
| 2023-11-22 | 2023-11-21 | 4 | Kovacs Shane William Charles | OLMA | Common Stock | D | 14,8300 | −8 897 | −132 | 434 832 | ||||
| 2023-11-22 | 2023-11-20 | 4 | Kovacs Shane William Charles | OLMA | Common Stock | D | 36 750 | 443 729 | ||||||
| 2023-11-22 | 2023-11-22 | 4 | Myles David C. | OLMA | Common Stock | D | 13,8900 | −6 653 | −92 | 574 099 | ||||
| 2023-11-22 | 2023-11-21 | 4 | Myles David C. | OLMA | Common Stock | D | 15,3200 | −200 | −3 | 580 752 | ||||
| 2023-11-22 | 2023-11-21 | 4 | Myles David C. | OLMA | Common Stock | D | 14,8700 | −6 776 | −101 | 580 952 | ||||
| 2023-11-22 | 2023-11-20 | 4 | Myles David C. | OLMA | Common Stock | D | 26 250 | 587 728 | ||||||
| 2023-11-22 | 2023-11-22 | 4 | Bohen Sean | OLMA | Common Stock | D | 13,9000 | −27 932 | −388 | 144 925 | ||||
| 2023-11-22 | 2023-11-21 | 4 | Bohen Sean | OLMA | Common Stock | D | 15,2900 | −2 602 | −40 | 172 857 | ||||
| 2023-11-22 | 2023-11-21 | 4 | Bohen Sean | OLMA | Common Stock | D | 14,8400 | −26 691 | −396 | 175 459 | ||||
| 2023-11-22 | 2023-11-20 | 4 | Bohen Sean | OLMA | Common Stock | D | 110 250 | 202 150 | ||||||
| 2023-11-22 | 2023-11-22 | 4 | Zojwalla Naseem | OLMA | Common Stock | D | 13,8900 | −7 095 | −99 | 30 664 | ||||
| 2023-11-22 | 2023-11-21 | 4 | Zojwalla Naseem | OLMA | Common Stock | D | 15,3300 | −200 | −3 | 37 759 | ||||
| 2023-11-22 | 2023-11-21 | 4 | Zojwalla Naseem | OLMA | Common Stock | D | 14,8300 | −7 261 | −108 | 37 959 | ||||
| 2023-11-22 | 2023-11-20 | 4 | Zojwalla Naseem | OLMA | Common Stock | D | 28 000 | 45 220 | ||||||
| 2023-11-22 | 2023-11-22 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 13,9000 | −3 989 | −55 | 951 283 | ||||
| 2023-11-22 | 2023-11-21 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 14,8600 | −4 192 | −62 | 955 272 | ||||
| 2023-11-22 | 2023-11-20 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 15 750 | 959 464 | ||||||
| 2023-11-13 | 2023-11-08 | 4 | Myles David C. | OLMA | Common Stock | D | 17,6100 | −200 | −4 | 561 270 | ||||
| 2023-11-03 | 2023-11-03 | 4 | Myles David C. | OLMA | Common Stock | D | 17,5100 | −541 | −9 | 561 470 | ||||
| 2023-11-03 | 2023-11-02 | 4 | Myles David C. | OLMA | Common Stock | D | 15,3600 | −3 332 | −51 | 562 011 | ||||
| 2023-11-03 | 2023-11-01 | 4 | Myles David C. | OLMA | Common Stock | D | 15,0200 | −6 668 | −100 | 565 343 | ||||
| 2023-11-02 | 2023-11-02 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 15,6400 | −5 000 | −78 | 943 714 | ||||
| 2023-11-02 | 2023-10-31 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 12,0500 | −25 000 | −301 | 948 714 | ||||
| 2023-10-03 | 2023-09-29 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 12,4100 | −25 000 | −310 | 973 714 | ||||
| 2023-09-21 | 3 | Paradigm Biocapital Advisors LP By: One or more separately managed accounts | OLMA | Common Stock, par value $0.0001 per share | I | 1 312 619 | ||||||||
| 2023-09-21 | 3 | Paradigm Biocapital Advisors LP By: Paradigm BioCapital International Fund Ltd. | OLMA | Common Stock, par value $0.0001 per share | I | 6 490 981 | ||||||||
| 2023-09-21 | 2023-09-19 | 4 | Myles David C. | OLMA | Common Stock | D | 12,6700 | −20 000 | −253 | 572 011 | ||||
| 2023-09-14 | 2023-09-14 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | I | 99 556 | 99 556 | ||||||
| 2023-09-14 | 2023-09-12 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | 9,8400 | 52 801 | 520 | 524 151 | ||||
| 2023-09-14 | 2023-09-12 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | 9,8400 | 677 853 | 6 670 | 3 584 512 | ||||
| 2023-09-14 | 2023-09-12 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | 9,8400 | 775 278 | 7 629 | 4 688 954 | ||||
| 2023-09-05 | 2023-09-05 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 11,6200 | −10 000 | −116 | 998 714 | ||||
| 2023-09-05 | 2023-08-31 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 9,3600 | −15 000 | −140 | 1 008 714 | ||||
| 2023-09-05 | 2023-08-16 | 4/A | Harmon Cyrus | OLMA | Common Stock | D | 10,1400 | −15 000 | −152 | 1 023 714 | ||||
| 2023-08-17 | 2023-08-16 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 10,1400 | −15 000 | −152 | 1 023 714 | ||||
| 2023-06-09 | 2023-06-08 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 6,3000 | −10 000 | −63 | 1 038 714 | ||||
| 2023-06-07 | 2023-06-06 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 6,2950 | −5 000 | −31 | 1 048 714 | ||||
| 2023-06-07 | 2023-06-05 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 6,0450 | −5 000 | −30 | 1 053 714 | ||||
| 2023-04-07 | 2023-04-06 | 4 | Kovacs Shane William Charles | OLMA | Common Stock | D | 10 000 | 396 197 | ||||||
| 2022-09-23 | 2022-09-21 | 4/A | Bohen Sean | OLMA | Common Stock | D | 20 000 | 74 279 | ||||||
| 2022-09-22 | 2022-09-21 | 4 | Bohen Sean | OLMA | Common Stock | D | 20 000 | 74 279 | ||||||
| 2022-09-06 | 2022-09-02 | 4 | Kovacs Shane William Charles | OLMA | Common Stock | D | 20 000 | 381 197 | ||||||
| 2022-06-14 | 2022-06-10 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | 4,0345 | 41 417 | 167 | 2 906 659 | ||||
| 2022-06-14 | 2022-06-10 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | 4,0345 | 158 583 | 640 | 3 913 676 | ||||
| 2022-03-14 | 2022-03-10 | 4 | Horn Kinney | OLMA | Stock Option (Right to Buy) | D | 2,06 | −5 253 | 141 785 | |||||
| 2022-03-14 | 2022-03-10 | 4 | Horn Kinney | OLMA | Common Stock | D | 4,7500 | −5 253 | −25 | 2 458 | ||||
| 2022-03-14 | 2022-03-10 | 4 | Horn Kinney | OLMA | Common Stock | D | 2,0640 | 5 253 | 11 | 7 711 | ||||
| 2022-02-14 | 2022-02-10 | 4 | Horn Kinney | OLMA | Stock Option (Right to Buy) | D | 2,06 | −5 251 | 147 038 | |||||
| 2022-02-14 | 2022-02-10 | 4 | Horn Kinney | OLMA | Common Stock | D | −5 251 | 2 458 | ||||||
| 2022-02-14 | 2022-02-10 | 4 | Horn Kinney | OLMA | Common Stock | D | 2,0640 | 5 251 | 11 | 7 709 | ||||
| 2022-02-03 | 2022-02-01 | 4 | Myles David C. | OLMA | Stock Option (Right to Buy) | D | 7,02 | 118 750 | 118 750 | |||||
| 2022-02-03 | 2022-02-01 | 4 | Kushner Peter J. | OLMA | Stock Option (Right to Buy) | D | 7,02 | 61 750 | 61 750 | |||||
| 2022-02-03 | 2022-02-01 | 4 | Harmon Cyrus | OLMA | Stock Option (Right to Buy) | D | 7,02 | 104 500 | 104 500 | |||||
| 2022-02-03 | 2022-02-01 | 4 | Horn Kinney | OLMA | Stock Option (Right to Buy) | D | 7,02 | 133 000 | 133 000 | |||||
| 2022-02-03 | 2022-02-01 | 4 | Moriarty John B | OLMA | Stock Option (Right to Buy) | D | 7,02 | 166 250 | 166 250 | |||||
| 2022-02-03 | 2022-02-01 | 4 | Kovacs Shane William Charles | OLMA | Stock Option (Right to Buy) | D | 7,02 | 247 000 | 247 000 | |||||
| 2022-02-03 | 2022-02-01 | 4 | Bohen Sean | OLMA | Stock Option (Right to Buy) | D | 7,02 | 812 250 | 812 250 | |||||
| 2022-02-03 | 2022-02-01 | 4 | Zojwalla Naseem | OLMA | Stock Option (Right to Buy) | D | 7,02 | 250 000 | 250 000 | |||||
| 2022-01-11 | 2022-01-10 | 4 | Horn Kinney | OLMA | Stock Option (Right to Buy) | D | 2,06 | −5 251 | 152 289 | |||||
| 2022-01-11 | 2022-01-10 | 4 | Horn Kinney | OLMA | Common Stock | D | 6,8500 | −5 251 | −36 | 2 458 | ||||
| 2022-01-11 | 2022-01-10 | 4 | Horn Kinney | OLMA | Common Stock | D | 2,0640 | 5 251 | 11 | 7 709 | ||||
| 2021-12-14 | 2021-12-10 | 4 | Horn Kinney | OLMA | Stock Option (Right to Buy) | D | 2,06 | −5 251 | 157 540 | |||||
| 2021-12-14 | 2021-12-10 | 4 | Horn Kinney | OLMA | Common Stock | D | 10,3900 | −5 251 | −55 | 2 458 | ||||
| 2021-12-14 | 2021-12-10 | 4 | Horn Kinney | OLMA | Common Stock | D | 2,0640 | 5 251 | 11 | 7 709 | ||||
| 2021-12-14 | 2021-12-10 | 4 | Myles David C. | OLMA | Common Stock | D | 10,3000 | −10 000 | −103 | 582 901 | ||||
| 2021-12-02 | 2021-11-30 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | 9,3903 | 35 268 | 331 | 471 350 | ||||
| 2021-12-02 | 2021-11-30 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | 9,3903 | 341 977 | 3 211 | 2 865 242 | ||||
| 2021-12-02 | 2021-11-30 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | 9,3903 | 362 430 | 3 403 | 3 755 093 | ||||
| 2021-12-01 | 2021-11-29 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 24,7600 | −400 | −10 | 1 051 146 | ||||
| 2021-11-12 | 2021-11-10 | 4 | Horn Kinney | OLMA | Stock Option (Right to Buy) | D | 19,00 | −22 417 | 67 253 | |||||
| 2021-11-12 | 2021-11-10 | 4 | Horn Kinney | OLMA | Stock Option (Right to Buy) | D | 2,06 | −5 251 | 162 791 | |||||
| 2021-11-12 | 2021-11-10 | 4 | Horn Kinney | OLMA | Common Stock | D | 26,8800 | −27 668 | −744 | 1 790 | ||||
| 2021-11-12 | 2021-11-10 | 4 | Horn Kinney | OLMA | Common Stock | D | 19,0000 | 22 417 | 426 | 29 458 | ||||
| 2021-11-12 | 2021-11-10 | 4 | Horn Kinney | OLMA | Common Stock | D | 2,0640 | 5 251 | 11 | 7 041 | ||||
| 2021-10-21 | 2021-10-19 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 28,2000 | −4 555 | −128 | 1 051 546 | ||||
| 2021-10-21 | 2021-10-19 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 27,8500 | −7 445 | −207 | 1 056 101 | ||||
| 2021-10-15 | 2021-10-14 | 4 | Bohen Sean | OLMA | Stock Option (Right to Buy) | D | 4,82 | −5 000 | 966 316 | |||||
| 2021-10-15 | 2021-10-14 | 4 | Bohen Sean | OLMA | Common Stock | D | 31,1700 | −351 | −11 | 52 514 | ||||
| 2021-10-15 | 2021-10-14 | 4 | Bohen Sean | OLMA | Common Stock | D | 30,4200 | −4 649 | −141 | 52 865 | ||||
| 2021-10-15 | 2021-10-14 | 4 | Bohen Sean | OLMA | Common Stock | D | 4,8240 | 5 000 | 24 | 57 514 | ||||
| 2021-10-12 | 2021-10-11 | 4 | Horn Kinney | OLMA | Stock Option (Right to Buy) | D | 2,06 | −5 251 | 168 042 | |||||
| 2021-10-12 | 2021-10-11 | 4 | Horn Kinney | OLMA | Common Stock | D | 28,1900 | −3 146 | −89 | 1 790 | ||||
| 2021-10-12 | 2021-10-11 | 4 | Horn Kinney | OLMA | Common Stock | D | 27,4700 | −2 105 | −58 | 4 936 | ||||
| 2021-10-12 | 2021-10-11 | 4 | Horn Kinney | OLMA | Common Stock | D | 2,0640 | 5 251 | 11 | 7 041 | ||||
| 2021-09-29 | 2021-09-27 | 4 | Bohen Sean | OLMA | Stock Option (Right to Buy) | D | 4,82 | −1 085 | 971 316 | |||||
| 2021-09-29 | 2021-09-27 | 4 | Bohen Sean | OLMA | Common Stock | D | 30,0700 | −1 085 | −33 | 52 514 | ||||
| 2021-09-29 | 2021-09-27 | 4 | Bohen Sean | OLMA | Common Stock | D | 4,8240 | 1 085 | 5 | 53 599 | ||||
| 2021-09-21 | 2021-09-20 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 26,3000 | −12 000 | −316 | 1 063 546 | ||||
| 2021-09-13 | 2021-09-10 | 4 | Horn Kinney | OLMA | Stock Option (Right to Buy) | D | 2,06 | −5 251 | 173 293 | |||||
| 2021-09-13 | 2021-09-10 | 4 | Horn Kinney | OLMA | Common Stock | D | 29,3800 | −5 251 | −154 | 1 790 | ||||
| 2021-09-13 | 2021-09-10 | 4 | Horn Kinney | OLMA | Common Stock | D | 2,0640 | 5 251 | 11 | 7 041 | ||||
| 2021-09-09 | 2021-09-08 | 4 | Bohen Sean | OLMA | Stock Option (Right to Buy) | D | 4,82 | −2 631 | 972 401 | |||||
| 2021-09-09 | 2021-09-08 | 4 | Bohen Sean | OLMA | Common Stock | D | 30,0000 | −2 631 | −79 | 52 514 | ||||
| 2021-09-09 | 2021-09-08 | 4 | Bohen Sean | OLMA | Common Stock | D | 4,8240 | 2 631 | 13 | 56 905 | ||||
| 2021-09-09 | 2021-09-07 | 4 | Bohen Sean | OLMA | Stock Option (Right to Buy) | D | 4,82 | −413 | 975 032 | |||||
| 2021-09-09 | 2021-09-07 | 4 | Bohen Sean | OLMA | Common Stock | D | 30,0800 | −413 | −12 | 54 274 | ||||
| 2021-09-09 | 2021-09-07 | 4 | Bohen Sean | OLMA | Common Stock | D | 4,8240 | 413 | 2 | 54 687 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Bohen Sean | OLMA | Stock Option (Right to Buy) | D | 4,82 | −871 | 975 445 | |||||
| 2021-09-03 | 2021-09-01 | 4 | Bohen Sean | OLMA | Common Stock | D | 30,0500 | −871 | −26 | 54 274 | ||||
| 2021-09-03 | 2021-09-01 | 4 | Bohen Sean | OLMA | Common Stock | D | 4,8240 | 871 | 4 | 55 145 | ||||
| 2021-08-20 | 2021-08-19 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 24,9700 | −12 000 | −300 | 1 075 546 | ||||
| 2021-08-11 | 2021-08-10 | 4 | Horn Kinney | OLMA | Stock Option (Right to Buy) | D | 2,06 | −5 251 | 178 544 | |||||
| 2021-08-11 | 2021-08-10 | 4 | Horn Kinney | OLMA | Common Stock | D | 26,1700 | −60 | −2 | 1 790 | ||||
| 2021-08-11 | 2021-08-10 | 4 | Horn Kinney | OLMA | Common Stock | D | 25,7000 | −5 191 | −133 | 1 850 | ||||
| 2021-08-11 | 2021-08-10 | 4 | Horn Kinney | OLMA | Common Stock | D | 2,0640 | 5 251 | 11 | 7 041 | ||||
| 2021-07-21 | 2021-07-20 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 25,6300 | −4 123 | −106 | 1 087 546 | ||||
| 2021-07-21 | 2021-07-19 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 24,8300 | −7 877 | −196 | 1 091 669 | ||||
| 2021-07-13 | 2021-07-12 | 4 | Horn Kinney | OLMA | Stock Option (Right to Buy) | D | 2,06 | −5 251 | 183 795 | |||||
| 2021-07-13 | 2021-07-12 | 4 | Horn Kinney | OLMA | Common Stock | D | 27,0000 | −1 392 | −38 | 1 790 | ||||
| 2021-07-13 | 2021-07-12 | 4 | Horn Kinney | OLMA | Common Stock | D | 26,3300 | −3 859 | −102 | 3 182 | ||||
| 2021-07-13 | 2021-07-12 | 4 | Horn Kinney | OLMA | Common Stock | D | 2,0640 | 5 251 | 11 | 7 041 | ||||
| 2021-06-21 | 2021-06-18 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 26,3000 | −600 | −16 | 1 099 546 | ||||
| 2021-06-21 | 2021-06-18 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 25,5900 | −1 990 | −51 | 1 100 146 | ||||
| 2021-06-21 | 2021-06-18 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 24,5400 | −9 410 | −231 | 1 102 136 | ||||
| 2021-06-11 | 2021-06-10 | 4 | Horn Kinney | OLMA | Stock Option (right to buy) | D | 2,06 | −5 251 | 189 046 | |||||
| 2021-06-11 | 2021-06-10 | 4 | Horn Kinney | OLMA | Common Stock | D | 29,9700 | −2 787 | −84 | 1 790 | ||||
| 2021-06-11 | 2021-06-10 | 4 | Horn Kinney | OLMA | Common Stock | D | 29,6000 | −2 164 | −64 | 4 577 | ||||
| 2021-06-11 | 2021-06-10 | 4 | Horn Kinney | OLMA | Common Stock | D | 28,3000 | −300 | −8 | 6 741 | ||||
| 2021-06-11 | 2021-06-10 | 4 | Horn Kinney | OLMA | Common Stock | D | 2,0640 | 5 251 | 11 | 7 041 | ||||
| 2021-06-10 | 2021-06-09 | 4 | Hrustanovic Gorjan | OLMA | Stock Option (right to buy) | D | 27,66 | 21 520 | 21 520 | |||||
| 2021-06-10 | 2021-06-09 | 4 | Horning Sandra | OLMA | Stock Option (right to buy) | D | 27,66 | 21 520 | 21 520 | |||||
| 2021-06-10 | 2021-06-09 | 4 | CLARK IAN T | OLMA | Stock Option (right to buy) | D | 27,66 | 21 520 | 21 520 | |||||
| 2021-06-10 | 2021-06-09 | 4 | Graham G. Walmsley | OLMA | Stock Option (right to buy) | D | 27,66 | 21 520 | 21 520 | |||||
| 2021-06-10 | 2021-06-09 | 4 | BUTITTA CYNTHIA M | OLMA | Stock Option (right to buy) | D | 27,66 | 21 520 | 21 520 | |||||
| 2021-06-10 | 2021-06-09 | 4 | RAPPAPORT ANDREW | OLMA | Stock Option (right to buy) | D | 27,66 | 21 520 | 21 520 | |||||
| 2021-06-10 | 2021-06-09 | 4 | Larson Yi | OLMA | Stock Option (right to buy) | D | 27,66 | 21 520 | 21 520 | |||||
| 2021-05-26 | 2021-03-31 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | I | 99 556 | 99 556 | ||||||
| 2021-05-19 | 2021-05-18 | 4 | Horn Kinney | OLMA | Stock Option (Right to Buy) | D | 2,06 | −57 763 | 194 297 | |||||
| 2021-05-19 | 2021-05-18 | 4 | Horn Kinney | OLMA | Common Stock | D | 24,8100 | −8 621 | −214 | 1 790 | ||||
| 2021-05-19 | 2021-05-18 | 4 | Horn Kinney | OLMA | Common Stock | D | 24,0300 | −49 142 | −1 181 | 10 411 | ||||
| 2021-05-19 | 2021-05-18 | 4 | Horn Kinney | OLMA | Common Stock | D | 2,0640 | 57 763 | 119 | 59 553 | ||||
| 2021-04-06 | 2021-04-05 | 4 | Larson Yi | OLMA | Stock Option (Right to Buy) | D | 34,80 | 3 773 | 3 773 | |||||
| 2021-04-06 | 2021-04-05 | 4 | Larson Yi | OLMA | Stock Option (Right to Buy) | D | 34,80 | 21 520 | 21 520 | |||||
| 2021-03-16 | 2021-03-15 | 4 | Horn Kinney | OLMA | Stock Option (Right to Buy) | D | 45,63 | 40 000 | 40 000 | |||||
| 2021-03-16 | 2021-03-15 | 4 | Bohen Sean | OLMA | Stock Option (Right to Buy) | D | 45,63 | 75 000 | 75 000 | |||||
| 2020-11-24 | 2020-11-23 | 4 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | OLMA | Series C Preferred Stock | D | −451 986 | 0 | ||||||
| 2020-11-24 | 2020-11-23 | 4 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | OLMA | Series B Preferred Stock | D | −1 273 420 | 0 | ||||||
| 2020-11-24 | 2020-11-23 | 4 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | OLMA | Common Stock | D | 451 986 | 1 725 406 | ||||||
| 2020-11-24 | 2020-11-23 | 4 | Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | OLMA | Common Stock | D | 1 273 420 | 1 273 420 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | Kushner Peter J. | OLMA | Series A-1 Convertible Preferred Stock | D | −130 159 | 0 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | Kushner Peter J. | OLMA | Series A Convertible Preferred Stock | D | −228 761 | 0 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | Kushner Peter J. | OLMA | Common Stock | D | 130 159 | 1 431 672 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | Kushner Peter J. | OLMA | Common Stock | D | 228 761 | 1 301 513 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | MCCORMICK FRANK | OLMA | Series A Convertible Preferred Stock | I | −66 326 | 0 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | MCCORMICK FRANK | OLMA | Series A-1 Convertible Preferred Stock | D | −152 891 | 0 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | MCCORMICK FRANK | OLMA | Common Stock | I | 66 326 | 84 260 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | MCCORMICK FRANK | OLMA | Common Stock | D | 152 891 | 191 113 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | RAPPAPORT ANDREW | OLMA | Series A-1 Convertible Preferred Stock | I | −129 833 | 0 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | RAPPAPORT ANDREW | OLMA | Series A Convertible Preferred Stock | I | −318 723 | 0 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | RAPPAPORT ANDREW | OLMA | Common Stock | I | 129 833 | 481 014 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | RAPPAPORT ANDREW | OLMA | Common Stock | I | 318 723 | 351 181 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | Graham G. Walmsley | OLMA | Series C Convertible Preferred Stock | I | −1 183 114 | 0 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | Graham G. Walmsley | OLMA | Series B Convertible Preferred Stock | I | −1 400 761 | 0 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | Graham G. Walmsley | OLMA | Common Stock | I | 19,0000 | 1 160 000 | 22 040 | 1 160 000 | ||||
| 2020-11-23 | 2020-11-23 | 4 | Graham G. Walmsley | OLMA | Common Stock | I | 1 183 114 | 1 183 114 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | Graham G. Walmsley | OLMA | Common Stock | I | 1 400 761 | 1 400 761 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | Cormorant Asset Management, LLC See Footnotes | OLMA | Series C Convertible Preferred Stock | I | −723 177 | 0 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | Cormorant Asset Management, LLC See Footnotes | OLMA | Series B Convertible Preferred Stock | I | −2 122 367 | 0 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | Cormorant Asset Management, LLC See Footnotes | OLMA | Common Stock | I | 19,0000 | 425 000 | 8 075 | 3 270 544 | ||||
| 2020-11-23 | 2020-11-23 | 4 | Cormorant Asset Management, LLC See Footnotes | OLMA | Common Stock | I | 2 845 544 | 2 845 544 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | Myles David C. | OLMA | Series A Convertible Preferred Stock | I | −154 846 | 0 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | Myles David C. | OLMA | Series A Convertible Preferred Stock | I | −12 831 | 0 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | Myles David C. | OLMA | Common Stock | I | 154 846 | 154 846 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | Myles David C. | OLMA | Common Stock | I | 12 831 | 12 831 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | Harmon Cyrus | OLMA | Series A Convertible Preferred Stock | I | −122 028 | 0 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | Harmon Cyrus | OLMA | Series A Convertible Preferred Stock | D | −71 374 | 0 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | Harmon Cyrus | OLMA | Common Stock | I | 122 028 | 122 028 | ||||||
| 2020-11-23 | 2020-11-23 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 71 374 | 1 111 546 | ||||||
| 2020-11-20 | 2020-11-19 | 4 | BVF PARTNERS L P/IL | OLMA | Series C Convertible Preferred Stock | D | −73 399 | 0 | ||||||
| 2020-11-20 | 2020-11-19 | 4 | BVF PARTNERS L P/IL | OLMA | Series C Convertible Preferred Stock | D | −522 403 | 0 | ||||||
| 2020-11-20 | 2020-11-19 | 4 | BVF PARTNERS L P/IL | OLMA | Series C Convertible Preferred Stock | D | −760 155 | 0 | ||||||
| 2020-11-20 | 2020-11-19 | 4 | BVF PARTNERS L P/IL | OLMA | Series B Convertible Preferred Stock | D | −101 784 | 0 | ||||||
| 2020-11-20 | 2020-11-19 | 4 | BVF PARTNERS L P/IL | OLMA | Series B Convertible Preferred Stock | D | −673 281 | 0 | ||||||
| 2020-11-20 | 2020-11-19 | 4 | BVF PARTNERS L P/IL | OLMA | Series B Convertible Preferred Stock | D | −889 186 | 0 | ||||||
| 2020-11-20 | 2020-11-19 | 4 | BVF PARTNERS L P/IL | OLMA | Series A-1 Convertible Preferred Stock | D | −185 908 | 0 | ||||||
| 2020-11-20 | 2020-11-19 | 4 | BVF PARTNERS L P/IL | OLMA | Series A-1 Convertible Preferred Stock | D | −881 156 | 0 | ||||||
| 2020-11-20 | 2020-11-19 | 4 | BVF PARTNERS L P/IL | OLMA | Series A-1 Convertible Preferred Stock | D | −1 129 404 | 0 | ||||||
| 2020-11-20 | 2020-11-19 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | 19,0000 | 74 991 | 1 425 | 436 082 | ||||
| 2020-11-20 | 2020-11-19 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | 73 399 | 361 091 | ||||||
| 2020-11-20 | 2020-11-19 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | 101 784 | 287 692 | ||||||
| 2020-11-20 | 2020-11-19 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | 185 908 | 185 908 | ||||||
| 2020-11-20 | 2020-11-19 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | 19,0000 | 446 425 | 8 482 | 2 523 265 | ||||
| 2020-11-20 | 2020-11-19 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | 522 403 | 2 076 840 | ||||||
| 2020-11-20 | 2020-11-19 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | 673 281 | 1 554 437 | ||||||
| 2020-11-20 | 2020-11-19 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | 881 156 | 881 156 | ||||||
| 2020-11-20 | 2020-11-19 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | 19,0000 | 613 918 | 11 664 | 3 392 663 | ||||
| 2020-11-20 | 2020-11-19 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | 760 155 | 2 778 745 | ||||||
| 2020-11-20 | 2020-11-19 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | 889 186 | 2 018 590 | ||||||
| 2020-11-20 | 2020-11-19 | 4 | BVF PARTNERS L P/IL | OLMA | Common stock, $0.0001 par value | D | 1 129 404 | 1 129 404 | ||||||
| 2020-11-20 | 2020-11-18 | 4 | BVF PARTNERS L P/IL | OLMA | Stock Option (Right to buy) | I | 19,00 | 21 520 | 21 520 | |||||
| 2020-11-20 | 2020-11-18 | 4 | BVF PARTNERS L P/IL | OLMA | Stock Option (Right to buy) | I | 19,00 | 21 520 | 21 520 | |||||
| 2020-11-20 | 2020-11-18 | 4 | BVF PARTNERS L P/IL | OLMA | Stock Option (Right to buy) | I | 19,00 | 21 520 | 21 520 | |||||
| 2020-11-19 | 2020-11-18 | 4 | BUTITTA CYNTHIA M | OLMA | Stock Option (Right to Buy) | D | 19,00 | 21 520 | 21 520 | |||||
| 2020-11-19 | 2020-09-16 | 4 | BUTITTA CYNTHIA M | OLMA | Stock Option (Right to Buy) | D | 4,41 | −83 876 | 0 | |||||
| 2020-11-19 | 2020-09-16 | 4 | BUTITTA CYNTHIA M | OLMA | Common Stock | D | 4,4060 | 83 876 | 370 | 83 876 | ||||
| 2020-11-19 | 2020-08-12 | 4 | BUTITTA CYNTHIA M | OLMA | Stock Option (Right to Buy) | D | 4,41 | 83 876 | 83 876 | |||||
| 2020-11-19 | 2020-11-18 | 4 | Kushner Peter J. | OLMA | Stock Option (Right to Buy) | D | 19,00 | 179 340 | 179 340 | |||||
| 2020-11-19 | 2020-06-15 | 4 | Kushner Peter J. | OLMA | Common Stock | D | 143 472 | 1 072 752 | ||||||
| 2020-11-19 | 2020-11-18 | 4 | MCCORMICK FRANK | OLMA | Stock Option (Right to Buy) | D | 19,00 | 21 520 | 21 520 | |||||
| 2020-11-19 | 2020-09-18 | 4 | MCCORMICK FRANK | OLMA | Stock Option (Right to Buy) | D | 4,82 | 56 964 | 56 964 | |||||
| 2020-11-19 | 2020-11-18 | 4 | Moriarty John B | OLMA | Stock Option (Right to Buy) | D | 19,00 | 161 406 | 161 406 | |||||
| 2020-11-19 | 2020-09-19 | 4 | Moriarty John B | OLMA | Stock Option (Right to Buy) | D | 4,82 | 252 060 | 252 060 | |||||
| 2020-11-19 | 2020-11-18 | 4 | Myles David C. | OLMA | Stock Option (Right to Buy) | D | 19,00 | 179 340 | 179 340 | |||||
| 2020-11-19 | 2020-06-15 | 4 | Myles David C. | OLMA | Common Stock | D | 143 472 | 591 821 | ||||||
| 2020-11-19 | 2020-11-18 | 4 | Graham G. Walmsley | OLMA | Stock Option (Right to Buy) | D | 19,00 | 21 520 | 21 520 | |||||
| 2020-11-19 | 2020-11-18 | 4 | Graham G. Walmsley | OLMA | Stock Option (Right to Buy) | D | 19,00 | 21 520 | 21 520 | |||||
| 2020-11-19 | 2020-11-18 | 4 | Graham G. Walmsley | OLMA | Stock Option (Right to Buy) | D | 19,00 | 21 520 | 21 520 | |||||
| 2020-11-19 | 2020-09-30 | 4 | Graham G. Walmsley | OLMA | Series C Convertible Preferred Stock | I | 11,0623 | 1 183 114 | 13 088 | 1 183 114 | ||||
| 2020-11-19 | 2020-06-01 | 4 | Graham G. Walmsley | OLMA | Series B Convertible Preferred Stock | I | 4,7117 | 339 578 | 1 600 | 339 578 | ||||
| 2020-11-19 | 2020-11-18 | 4 | RAPPAPORT ANDREW | OLMA | Stock Option (Right to Buy) | D | 19,00 | 21 520 | 21 520 | |||||
| 2020-11-19 | 2020-09-18 | 4 | RAPPAPORT ANDREW | OLMA | Stock Option (Right to Buy) | D | 4,82 | 56 964 | 56 964 | |||||
| 2020-11-19 | 2020-11-18 | 4 | Bohen Sean | OLMA | Stock Option (Right to Buy) | D | 19,00 | 538 020 | 538 020 | |||||
| 2020-11-19 | 2020-09-23 | 4 | Bohen Sean | OLMA | Stock Option (Right to Buy) | D | 4,82 | −51 649 | 976 316 | |||||
| 2020-11-19 | 2020-09-23 | 4 | Bohen Sean | OLMA | Common Stock | D | 4,8240 | 51 649 | 249 | 51 649 | ||||
| 2020-11-19 | 2020-09-19 | 4 | Bohen Sean | OLMA | Stock Option (Right to Buy) | D | 4,82 | 1 027 965 | 1 027 965 | |||||
| 2020-11-19 | 2020-09-19 | 4 | Bohen Sean | OLMA | Stock Option (Right to Buy) | D | 4,82 | 82 931 | 82 931 | |||||
| 2020-11-19 | 2020-11-18 | 4 | CLARK IAN T | OLMA | Stock Option (Right to Buy) | D | 19,00 | 21 520 | 21 520 | |||||
| 2020-11-19 | 2020-08-12 | 4 | CLARK IAN T | OLMA | Stock Option (Right to Buy) | D | 4,41 | 209 690 | 209 690 | |||||
| 2020-11-19 | 2020-11-18 | 4 | Horn Kinney | OLMA | Stock Option (Right to Buy) | D | 19,00 | 89 670 | 89 670 | |||||
| 2020-11-19 | 2020-06-10 | 4 | Horn Kinney | OLMA | Stock Option (Right to Buy) | D | 2,06 | 252 060 | 252 060 | |||||
| 2020-11-19 | 2020-11-18 | 4 | Harmon Cyrus | OLMA | Stock Option (Right to Buy) | D | 19,00 | 179 340 | 179 340 | |||||
| 2020-11-19 | 2020-09-12 | 4 | Harmon Cyrus | OLMA | Stock Option (Right to Buy) | D | 4,82 | 227 859 | 227 859 | |||||
| 2020-11-19 | 2020-06-15 | 4 | Harmon Cyrus | OLMA | Common Stock | D | 143 472 | 1 040 172 | ||||||
| 2020-11-19 | 2020-11-18 | 4 | Horning Sandra | OLMA | Stock Option (Right to Buy) | D | 19,00 | 86 083 | 86 083 | |||||
| 2020-11-19 | 2020-11-18 | 4 | Hrustanovic Gorjan | OLMA | Stock Option (Right to Buy) | D | 19,00 | 21 520 | 21 520 | |||||
| 2020-11-19 | 2020-11-18 | 4 | Hrustanovic Gorjan | OLMA | Stock Option (Right to Buy) | D | 19,00 | 21 520 | 21 520 | |||||
| 2020-11-19 | 2020-11-18 | 4 | Hrustanovic Gorjan | OLMA | Stock Option (Right to Buy) | D | 19,00 | 21 520 | 21 520 | |||||
| 2020-11-19 | 2020-11-18 | 4 | Kovacs Shane William Charles | OLMA | Stock Option (Right to Buy) | D | 19,00 | 107 604 | 107 604 | |||||
| 2020-11-19 | 2020-06-15 | 4 | Kovacs Shane William Charles | OLMA | Common Stock | D | 358 680 | 358 680 | ||||||
| 2020-11-19 | 3 | RAPPAPORT ANDREW | OLMA | Common Stock | I | 32 458 | ||||||||
| 2020-11-18 | 3 | MCCORMICK FRANK | OLMA | Common Stock | I | 17 934 | ||||||||
| 2020-11-18 | 3 | MCCORMICK FRANK | OLMA | Common Stock | D | 38 222 | ||||||||
| 2020-11-18 | 3 | Myles David C. | OLMA | Common Stock | D | 591 821 | ||||||||
| 2020-11-18 | 3 | Kushner Peter J. | OLMA | Common Stock | D | 1 072 752 | ||||||||
| 2020-11-18 | 3 | Kovacs Shane William Charles | OLMA | Common Stock | D | 358 680 | ||||||||
| 2020-11-18 | 3 | Harmon Cyrus | OLMA | Common Stock | D | 1 040 172 | ||||||||
| 2020-11-18 | 3 | Bohen Sean | OLMA | Common Stock | D | 51 649 | ||||||||
| 2020-11-18 | 3 | BUTITTA CYNTHIA M | OLMA | Common Stock | D | 83 876 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
